Paradoxical effects of minocycline in the developing mouse somatosensory cortex

GLIA

Volumn 62, Issue 3, 2014, Pages 399-410

  Arnoux, Isabelle ^a,b,c   Hoshiko, Maki ^a,b,c,d   Sanz Diez, Alvaro ^a,b,c   Audinat, Etienne ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Microglial activation; Neuroinflammation; Postnatal; Potassium channels

Indexed keywords

MINOCYCLINE; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; CALCIUM BINDING PROTEIN; CASPASE 3; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, MOUSE; GALECTIN 3; GREEN FLUORESCENT PROTEIN; KI 67 ANTIGEN; LEUKOCYTE ANTIGEN; NEUROPROTECTIVE AGENT; SLC17A7 PROTEIN, MOUSE; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BRAIN ELECTROPHYSIOLOGY; BRAIN NERVE CELL; CELL ACTIVATION; CELL FUNCTION; CELL STRUCTURE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; NONHUMAN; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SOMATOSENSORY CORTEX; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENETICS; GLIA; GROWTH, DEVELOPMENT AND AGING; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MEMBRANE POTENTIAL; METABOLISM; NEWBORN; PHYSIOLOGY; TRANSGENIC MOUSE; WHITE MATTER;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD; APOPTOSIS; CALCIUM-BINDING PROTEINS; CASPASE 3; GALECTIN 3; GREEN FLUORESCENT PROTEINS; IN VITRO TECHNIQUES; INJECTIONS, INTRAPERITONEAL; KI-67 ANTIGEN; MEMBRANE POTENTIALS; MICE; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MINOCYCLINE; NEUROGLIA; NEUROPROTECTIVE AGENTS; RECEPTORS, CHEMOKINE; SOMATOSENSORY CORTEX; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1; WHITE MATTER;

EID: 84892543619     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22612     Document Type: Article

References (46)

1. Arnoux I, Hoshiko M, Mandavy L, Avignone E, Yamamoto N, Audinat E. 2013. Adaptive phenotype of microglial cells during the normal postnatal development of the somatosensory "Barrel" cortex. Glia 61:1582-1594.
2. Bednarek N, Clement Y, Lelievre V, Olivier P, Loron G, Garnotel R, Gressens P. 2009. Ontogeny of MMPs and TIMPs in the murine neocortex. Pediatr Res 65:296-300.
3. Blank T, Prinz M. 2013. Microglia as modulators of cognition and neuropsychiatric disorders. Glia 61:62-70.
4. Bruno MA, Cuello AC. 2006. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc Natl Acad Sci USA 103:6735-6740.
5. Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM. 2000. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797-801.
6. Choi Y, Kim HS, Shin KY, Kim EM, Kim M, Kim HS, Park CH, Jeong YH, Yoo J, Lee JP, Chang KA, Kim S, Suh YH. 2007. Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 32:2393-2404.
7. Cunningham CL, Martinez-Cerdeno V, Noctor SC. 2013. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci 33:4216-4233.
8. Dheen ST, Kaur C, Ling EA. 2007. Microglial activation and its implications in the brain diseases. Curr Med Chem 14:1189-1197.
9. Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F. 2004. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci 19:3266-3276.
10. Domercq M, Matute C. 2004. Neuroprotection by tetracyclines. Trends Pharmacol Sci 25:609-612.
11. Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM. 2001. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 98:14669-14674.
12. Eder C. 1998. Ion channels in microglia (brain macrophages). Am J Physiol 275:C327-C342.
13. Frade JM, Barde YA. 1998. Microglia-derived nerve growth factor causes cell death in the developing retina. Neuron 20:35-41.
14. Hanisch UK, Kettenmann H. 2007. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387-1394.
15. Hoshiko M, Arnoux I, Avignone E, Yamamoto N, Audinat E. 2012. Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex. J Neurosci 32:15106-15111.
16. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S. 1996. A novel gene Iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 224:855-862.
17. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR. 2000. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20:4106-4114.
18. Kerschensteiner M, Stadelmann C, Dechant G, Wekerle H, Hohlfeld R. 2003. Neurotrophic cross-talk between the nervous and immune systems: Implications for neurological diseases. Ann Neurol 53:292-304.
19. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. 2011. Physiology of microglia. Physiol Rev 91:461-553.
20. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
21. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, Watkins LR. 2005. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115:71-83.
22. Lee R, Kermani P, Teng KK, Hempstead BL. 2001. Regulation of cell survival by secreted proneurotrophins. Science 294:1945-1948.
23. Lenz KM, Nugent BM, Haliyur R, McCarthy MM. 2013. Microglia are essential to masculinization of brain and behavior. J Neurosci 33:2761-2772.
24. Lund S, Christensen KV, Hedtjarn M, Mortensen AL, Hagberg H, Falsig J, Hasseldam H, Schrattenholz A, Porzgen P, Leist M. 2006. The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J Neuroimmunol 180:71-87.
25. Mallat M, Marin-Teva JL, Cheret C. 2005. Phagocytosis in the developing CNS: More than clearing the corpses. Curr Opin Neurobiol 15:101-107.
26. Marin-Teva JL, Dusart I, Colin C, Gervais A, van RN, Mallat M. 2004. Microglia promote the death of developing Purkinje cells. Neuron 41:535-547.
27. Menteyne A, Levavasseur F, Audinat E, Avignone E. 2009. Predominant functional expression of Kv1.3 by activated microglia of the hippocampus after status epilepticus. PLoS One 4:e6770.
28. Napoli I, Neumann H. 2009a. Microglial clearance function in health and disease. Neuroscience 158:1030-1038.
29. Napoli I, Neumann H. 2010. Protective effects of microglia in multiple sclerosis. Exp Neurol 225:24-28.
30. Nikodemova M, Lee J, Fabry Z, Duncan ID. 2010. Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord. J Neuroimmunol 219:33-37.
31. Nutile-McMenemy N, Elfenbein A, Deleo JA. 2007. Minocycline decreases in vitro microglial motility, β1-integrin, and Kv1.3 channel expression. J Neurochem 103:2035-2046.
32. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Dumas L, Ragozzino D, Gross CT. 2011. Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456-1458.
33. Pont-Lezica L, Bechade C, Belarif-Cantaut Y, Pascual O, Bessis A. 2011. Physiological roles of microglia during development. J Neurochem 119:901-908.
34. Ransohoff RM, Perry VH. 2009. Microglial physiology: Unique stimuli, specialized responses. Annu Rev Immunol 27:119-145.
35. Roy A, Jana A, Yatish K, Freidt MB, Fung YK, Martinson JA, Pahan K. 2008. Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases. Free Radic Biol Med 45:686-699.
36. Ryu JK, Franciosi S, Sattayaprasert P, Kim SU, McLarnon JG. 2004. Minocycline inhibits neuronal death and glial activation induced by β-amyloid peptide in rat hippocampus. Glia 48:85-90.
37. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B. 2012. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74:691-705.
38. Schafer DP, Lehrman EK, Stevens B. 2013. The "quad-partite" synapse: Microglia-synapse interactions in the developing and mature CNS. Glia 61:24-36.
39. Siller SS, Broadie K. 2012. Matrix metalloproteinases and minocycline: Therapeutic avenues for fragile X syndrome. Neural Plast 2012:124548.
40. Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W. 2005. Minocycline as a neuroprotective agent. Neuroscientist 11:308-322.
41. Tikka TM, Koistinaho JE. 2001. Minocycline provides neuroprotection against N-methyl-d-aspartate neurotoxicity by inhibiting microglia. J Immunol 166:7527-7533.
42. Tsuji M, Wilson MA, Lange MS, Johnston MV. 2004. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 189:58-65.
43. Ueno M, Fujita Y, Tanaka T, Nakamura Y, Kikuta J, Ishii M, Yamashita T. 2013. Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci 16:543-551.
44. Wakselman S, Bechade C, Roumier A, Bernard D, Triller A, Bessis A. 2008. Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J Neurosci 28:8138-8143.
45. Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S, Shin DH, Browne SE, Shimizu Y, Joh TH, Beal MF, Albers DS. 2003. Minocycline enhances MPTP toxicity to dopaminergic neurons. J Neurosci Res 74:278-285.
46. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769-15774.